ArticlePloS one2026
Emerging tobacco use patterns in the United States: Tobacco use behaviors associated with current use of nicotine pouches.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nicotine pouches (NPs) are non-combustible tobacco products marketed as alternatives to traditional tobacco. Recent studies suggest an increasing use of NPs in the United States. The primary goals of this study were to assess the associations between current use of each of the seven other tobacco products and current use of NPs among U.S. adults (18+), and to determine which other products are significantly associated with current use of NPs. The secondary goals were to describe the population of adults who currently use NPs in terms of their tobacco use behaviors and sociodemographic characteristics. Data from the 2022-2023 Tobacco Use Supplement (TUS) to the Current Population Survey (CPS), collected in the U.S., were used in this cross-sectional study to address the primary (n = 107,281) and secondary (n = 537) goals. The primary outcome was current NP use (yes/no). All analyses accounted for the TUS-CPS complex design. The prevalence of current NP use was 0.47% (SE = 0.03%), corresponding to an estimated 1,146,681 adults nationwide. Adults who currently used smokeless tobacco (aOR=12.03, 95% CI = 8.83-16.39) had the highest odds of current use of NPs, followed by those who used heated tobacco (aOR=4.84, 95% CI = 2.01-11.67), hookah tobacco (aOR=3.70, 95%CI = 1.55-8.82), e-cigarettes (aOR=2.90, 95% CI = 1.84-4.60), cigars (aOR=2.48, 95% CI = 1.71-3.58), and combustible cigarettes (aOR=1.84, 95% CI = 1.38-2.45). Among adults who currently use NPs, 61.00% (SE = 2.59%) used at least one other tobacco product and the most commonly used products were smokeless tobacco (27.39%), combustible cigarettes (21.74%), e-cigarettes (20.54%), and cigars (17.30%). The observed sociodemographic profile of adults who use NPs (e.g., 89.14% are men) suggests that NPs may be reaching subgroups that differ from those who typically use other tobacco products. The findings underscore the need for further research to determine whether use of NPs leads to product switching, cessation, or sustained poly-tobacco use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.